#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Vladimir Vainstein Email
Chief Medical Officer . Neumedicines
How to contact Vladimir Vainstein
Join and see Vladimir's contact info for free!Current Roles
Employees:
12Revenue:
$1.9MAbout
Neumedicines Inc. is an emerging therapeutic biotechnology company focused on developing and commercializing innovative and proprietary products and approaches that address unmet clinical and societal needs in the areas of oncology, hematology, and immunology. The company operates from its headquarters in Pasadena, California. Neumedicines' lead product candidate is recombinant human interleukin-12 (rHuIL-12), a heterodimeric glycoprotein and cytokine. rHuIL-12 is being developed under the trade name HemaMaxâ„¢ for various clinical indications, including hematopoietic syndrome of acute radiation syndrome (HSARS), skin cancers and other solid tumors, and blood disorders and malignancies.Neumedicines Address
133 North Altadena DrivePasadena, CA
United States